ArticleHeliyon2025
Diabetes mortality burden attributable to influenza in China: A population-based time-series analysis.
Article in Heliyon, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Diabetes Mellitus with Influenza Virus and Subsequent Bacterial Infection: Triple Pathological Interactions and Challenges.International journal of molecular sciences · 2026Review
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Previous studies have found an association between influenza, cardiovascular and cerebrovascular disease mortality, and all-cause mortality. And the vaccination of elderly diabetes is often recommended to reduce the risk of hospitalization and death. Nevertheless, no previous work has investigated the short-term impact of influenza on diabetes mortality in China. In this study, data from the national surveillance system was used to quantify the impact of influenza on diabetes-related mortality and provide guidance for the care of diabetes patients. Methods: Data from the National Influenza Surveillance Center was collected for the period between 2015 and 2019 and weekly diabetes-related deaths were calculated from China's Disease Surveillance Points System (CDSP). A distributed non-linear lag model (DLNM) was used to 1] analyze the delayed impact of high influenza virus-positive rates on diabetes-related mortality, 2] calculate the relative risk of diabetes deaths caused by high influenza virus-positive rate, and 3] estimate the attributable risk of diabetes deaths caused by influenza in China. Results: A total of 260 weeks of influenza weekly data from southern and northern China were included in this study. This resulted in 256,845 diabetes-related deaths with an average age of 73.36 years. During this period, the mean influenza virus-positive rate was 12.79 %. The relative risk of death from diabetes at high influenza positive rate was 1.33 (95 % CI [1.25, 1.40]) in southern China and 1.14 (95 % CI [1.08, 1.20]) in northern China for a 3-week lag. The estimated population attributable fraction (PAF) was 9.64 % (95 % CI [6.6 %, 12.55 %]) in southern China and 1.69 % (95 % CI [-0.04 %, 3.35 %]) in northern China. The present study suggest that reducing the influenza virus-positive rate to optimal levels could potentially prevent approximately 10,871 diabetes-related deaths annually. Conclusion: A high influenza virus-positive rate is associated with an increased risk of diabetes-related mortality. Moreover, this effect is consistent across geographical areas and gender groups. Overall, the present study suggests that the risk of diabetes-related mortality attributable to influenza is high in China.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.